oncopept

Russian peptide oncovaccine 'Oncopept' shows promise in early colorectal cancer trials

Early results of Russia's 'Oncopept' peptide oncovaccine for colorectal cancer show good tolerability and expected immune response. Over 40 patients are enrolled, primarily those with metastatic disease who have undergone surgery and chemotherapy.